Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Vscan [1400×150]

GE Vscan [1400x150]

Enovacom SickKids case study

Enovacom SickKids case study

People

New chief appointed at UHN Techna

April 13, 2022


Dr Shaf Keshavjee 2021TORONTO – UHN is pleased to announce that Dr. Shaf Keshavjee (pictured) has been named the new Techna scientific director and chief of clinical innovation at UHN. This leadership will advance UHN’s commitment to translating world-class discoveries into new treatments and technologies for a healthier world.

The appointments follow Dr. Keshavjee’s 12-year tenure as UHN’s surgeon-in-chief, through which he led the Sprott Department of Surgery through a period of many exciting changes, innovations and commercialization opportunities. He will remain UHN’s Surgeon-in-Chief until a new candidate is identified.

As Techna’s scientific director, he will lead the strategic transformation of the Research Institute into a technology accelerator platform. In addition to establishing a strong and engaged network of innovators across UHN, he will create and implement an innovation program that will identify and develop medical and digital health technologies. With the UHN Commercialization Team, he will advance the commercialization of scientific discoveries to the bedside to improve tomorrow’s healthcare.

Also, in this new evolved version of Techna, he will work cooperatively with Techna’s core platforms and other key technology expertise within and external to UHN.

In the new role of chief of clinical innovation at UHN, Dr. Keshavjee will cultivate and facilitate innovations destined for the patient bedside, including the implementation of new technologies and models of patient care throughout the organization. Dr. Keshavjee will collaborate with research, education and clinical experts to build a health technology innovation strategy and infrastructure to develop new, viable and scalable business opportunities. This will include leveraging Techna as a technology accelerator.

These activities are strongly aligned with the priorities of the UHN Foundation and The Princess Margaret Cancer Foundation and UHN’s many generous donors. Dr. Keshavjee will actively work with foundations and donors in attracting investments to advance key research, clinical and business initiatives.

Dr. Keshavjee’s past achievements and expertise are perfectly matched to inform and guide the adoption of new technologies at UHN. He has led clinical and research teams in lung transplantation, resulting in significant advances in the field and the translation of novel applications across organ transplantation. His pioneering research to recondition and repair injured human donor lungs with the Toronto Ex Vivo Lung Perfusion system has more than doubled the number of lung transplants performed each year at UHN. This technology is now being used at transplant centres around the world, including Asia, Australia, South America, Europe and the United States, and at leading centres such as Duke, Johns Hopkins, Cleveland Clinic and the Mayo Clinic.

PreviousNext

VG2022

VG2022

News and Trends

  • COVID-19 had a big impact on data management
  • GE to accelerate commercialization of AI innovations
  • Unique homecare EMR designed by clinicians for clinicians
  • London hospitals offer virtual-visits designed for inclusiveness
  • How technology can be deployed to assist the aged and their families
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

Infoway [May2022]

Infoway [May2022]

eHealth 2022

eHealth 2022

MEDICA 2022

MEDICA 2022

Advertise with us

Advertise with us

Calian-Fraser Health

Calian-Fraser Health

Sectra best in KLAS

Sectra best in KLAS

Zebra [May2022]

Zebra [May2022]

Cdn Institute HCI West

Cdn Institute HCI West

Talkdesk

Talkdesk

VG2022

VG2022

VG2022

VG2022

Advertise with us

Advertise with us

Calian-Fraser Health

Calian-Fraser Health

Sectra best in KLAS

Sectra best in KLAS

Zebra [May2022]

Zebra [May2022]

Cdn Institute HCI West

Cdn Institute HCI West

Talkdesk

Talkdesk

VG2022

VG2022

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2022 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us